|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 215.10 EUR | -2.18% |
|
-4.70% | +10.31% |
| 07-10 | Biopharma Pricing Power Seen as Key Swing Factor for Q2 Earnings, BofA Says | MT |
| 07-10 | BofA Securities Adjusts AbbVie Price Target to $276 From $234 | MT |
| Market Cap | 438B 383B 354B 327B 620B 41,803B 630B 4,225B 1,659B 20,593B 1,646B 1,610B 70,796B | P/E 2026 * |
30.1x | P/E 2027 * | 23.1x |
|---|---|---|---|---|---|
| Enterprise Value | 493B 431B 398B 368B 698B 47,049B 709B 4,755B 1,867B 23,178B 1,852B 1,812B 79,680B | EV / Sales 2026 * |
7.34x | EV / Sales 2027 * | 6.66x |
| Free-Float |
95.71% | Yield 2026 * |
2.76% | Yield 2027 * | 2.92% |
Last Transcript: AbbVie Inc.
| 1 day | -2.18% | ||
| 1 week | -4.70% | ||
| Current month | -2.05% | ||
| 1 month | +10.88% | ||
| 3 months | +19.00% | ||
| 6 months | +12.15% | ||
| Current year | +10.31% |
| 1 week | 215.1 |  | 227.5 |
| 1 month | 188.2 | | 227.5 |
| Current year | 167.55 | | 227.5 |
| 1 year | 157.2 | | 227.5 |
| 3 years | 119 | | 227.5 |
| 5 years | 89.89 | | 227.5 |
| 10 years | 50.18 | | 227.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 55 | 2024-06-30 |
Scott Reents
DFI | Director of Finance/CFO | 59 | 2022-06-22 |
Linda Ray
CTO | Chief Tech/Sci/R&D Officer | - | 2024-02-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 65 | 2012-12-31 |
William Burnside
BRD | Director/Board Member | 74 | 2012-12-31 |
Edward Rapp
BRD | Director/Board Member | 68 | 2012-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.18% | -4.70% | - | - | 438B | |
| -2.33% | -2.09% | +49.88% | +170.51% | 1,060B | |
| -0.82% | -2.30% | +63.79% | +62.00% | 619B | |
| +0.33% | -1.17% | +31.07% | +27.09% | 333B | |
| -0.02% | -2.85% | +29.15% | +45.24% | 282B | |
| -3.89% | -11.22% | +22.81% | +27.30% | 267B | |
| +0.66% | -1.42% | -26.59% | -37.71% | 218B | |
| -0.06% | -2.88% | +23.07% | +62.33% | 196B | |
| -3.72% | -1.10% | +18.41% | +70.56% | 161B | |
| -0.33% | -0.62% | -5.77% | -32.90% | 138B | |
| Average | -1.24% | -2.76% | +22.87% | +43.82% | 363.71B | |
| Weighted average by Cap. | -1.45% | -2.59% | +36.01% | +79.11% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 67.23B 58.81B 54.24B 50.1B 95.06B 6,412B 96.66B 648B 255B 3,159B 252B 247B 10,860B | 72.76B 63.64B 58.7B 54.22B 103B 6,940B 105B 701B 275B 3,419B 273B 267B 11,753B |
| Net income | 14.29B 12.5B 11.53B 10.65B 20.21B 1,363B 20.55B 138B 54.1B 671B 53.66B 52.49B 2,308B | 19.19B 16.78B 15.48B 14.3B 27.13B 1,830B 27.59B 185B 72.63B 901B 72.04B 70.47B 3,099B |
| Net Debt | 55B 48.11B 44.38B 40.99B 77.77B 5,246B 79.08B 530B 208B 2,584B 207B 202B 8,884B | 46.43B 40.61B 37.46B 34.6B 65.64B 4,428B 66.75B 448B 176B 2,181B 174B 171B 7,499B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-10 | €215.10 | -2.18% | 58 |
| 26-07-09 | €219.90 | -2.05% | 30 |
| 26-07-08 | €224.50 | -1.01% | 59 |
| 26-07-07 | €226.80 | +1.25% | 118 |
| 26-07-06 | €224.00 | -0.75% | 14 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABBV Stock
- 4AB Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
